Actively Recruiting

Phase Not Applicable
Age: 13Years - 17Years
All Genders
ID07301060

Optimizing a Sensor-Enabled mHealth Intervention for Adolescents With Suboptimal Asthma Control

Led by University of Kansas · Updated on 2025-12-24

160

Participants Needed

2

Research Sites

2 weeks

Total Duration

On this page

Sponsors

U

University of Kansas

Lead Sponsor

N

National Heart, Lung, and Blood Institute (NHLBI)

Collaborating Sponsor

AI-Summary

What this Trial Is About

Asthma affects nearly one in ten teenagers in the United States and can significantly impact their health and daily life. Teens are expected to manage their asthma by taking medications correctly and monitoring symptoms, but this can be challenging as adolescents are still developing self-management skills and often receive less parental support. This trial evaluates a new system called Responsive Asthma Care for Teens (ReACT), designed to provide personalized, real-time support to help teens improve their asthma management skills. The study aims to test the feasibility and potential benefits of ReACT compared to a standard asthma education and symptom logging approach in teens with poorly controlled asthma. The study involves 160 teenagers aged 13 to 17 with suboptimal asthma control who will be randomly assigned to one of two groups for six months. One group will use the ReACT system, which includes a sensor to monitor medication adherence, training in problem-solving skills, ongoing tailored text messages with feedback and encouragement, and general asthma education. The other group will receive the standard mHealth care involving the same sensor monitoring and symptom reporting but only general asthma education without tailored support. Both groups will use smartphone apps to log symptoms and medication use. Participants will be involved in assessments at the start, at three months, and at six months, including surveys and objective data collection from the sensors. Researchers will measure recruitment feasibility, retention, engagement, acceptability, usability of the system, and burden on participants. They will also evaluate asthma control and quality of life using standardized tests. The study will help determine if ReACT and the study procedures are ready for a larger trial and provide early data on ReACT's impact on asthma outcomes for teens.

CONDITIONS

Brief Title

Optimizing a Sensor-Enabled mHealth Intervention for Adolescents With Suboptimal Asthma Control

Who Can Participate

Age: 13Years - 17Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Between 13 and 17 years old
  • Physician-verified diagnosis of persistent asthma for at least 6 months
  • Suboptimal asthma control as defined by national asthma guidelines
  • Daily inhaled corticosteroid prescription compatible with the ReACT sensor
  • Adolescent and caregiver speak and read English
Not Eligible

You will not qualify if you...

  • Currently involved in an asthma management intervention beyond usual care
  • Comorbid chronic health condition affecting lung function (e.g., cystic fibrosis)
  • Significant cognitive impairment or developmental delay interfering with study completion
  • Does not have their own smartphone

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Outpatient Treatment

Duration - 6 months

Participants use a sensor to passively monitor adherence to their asthma regimen and report on their symptoms. Participants in the intervention arm receive tailored text messages with adherence feedback and problem-solving support, while participants in the control arm receive general asthma education.

Baseline visit and follow-up visits at 3 and 6 months

Trial Site Locations

Total: 2 locations

1

Nemours Children's Health

Jacksonville, Florida, United States, 32207

Actively Recruiting

2

University of Kanas

Lawrence, Kansas, United States, 66045

Actively Recruiting

Loading map...

Research Team

C

Christopher C. Cushing, Ph.D.

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

2

Similar Trials

Investigating Astaxanthin as a Novel Therapy for Asthma Mana...

Asthma (Diagnosis)

Actively Recruiting

1 location

Comparative Effects of Alternate Nostril Breathing Versus Bu...

Asthma (Diagnosis)

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here